XBI Trade Ideas

Recent trade ideas mentioning XBI

• AbbVie drops $10.9B on Apogee — ride the biotech buyout premium

  LONG · 2026-06-22

  Drug giant AbbVie just announced it is buying Apogee Therapeutics for $10.9 billion to expand its immunology portfolio.

• GSK drops $10 billion on a cancer drug company — speculate on the next biotech buyout targets

  LONG · 2026-06-09

  Pharmaceutical giant GSK just announced it is buying Nuvalent, a smaller company making promising lung cancer drugs, for over $10 billion. This marks the start of a major buying spree as big drug companies race to snap up innovative new treatments.

• Biotech M&A frenzy kicks off with $10.6B deal — target the next takeover candidates

  LONG · 2026-06-09

  GSK is buying Nuvalent for $10.6 billion to expand its lung cancer treatments. This highlights a massive wave of pharmaceutical companies buying up smaller biotech firms to replenish their drug pipelines.

• GSK just paid $10.6B for a cancer biotech — the M&A frenzy is lifting smaller drug stocks

  LONG · 2026-06-09

  British pharmaceutical giant GSK just agreed to buy biotech firm Nuvalent for $10.6 billion to strengthen its cancer treatment lineup. This is part of a massive wave of pharmaceutical companies buying up smaller biotech firms.

• GSK drops $10.6B on a cancer biotech — ride the biotech takeover wave

  LONG · 2026-06-09

  Pharmaceutical giant GSK just agreed to buy cancer-drug maker Nuvalent for $10.6 billion. This massive deal signals that big drug companies are in a spending mood to snap up innovative biotech firms.

• Weight-loss drugs are crushing it and big pharma is on a buying spree — jump on Eli Lilly and biotech

  LONG · 2026-06-09

  Eli Lilly just reported stellar results for its next weight-loss drug, and massive buyouts are sweeping the pharmaceutical industry as companies race to snap up the next big medical breakthrough.